Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.
about
Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience.Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests.Old medications and new targeted therapies in systemic sclerosis.Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?Systemic sclerosis--challenges for clinical practice.Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung diseaseManagement of connective tissue diseases associated interstitial lung disease: a review of the published literature.Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling.Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.Idiopathic or connective tissue disease-associated interstitial lung disease: a case of HRCT mimicry.Cyclophosphamide for connective tissue disease-associated interstitial lung disease.Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.Quantitative CT indexes are significantly associated with exercise oxygen desaturation in interstitial lung disease related to systemic sclerosis.Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography.Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.
P2860
Q33727800-4A16F070-4855-4D6D-94E9-BBB20AAF53EDQ34986829-A1C0AB52-4B2C-40D1-9A67-8ACCC31BEF7BQ36154430-1BE2C822-811D-4551-8B6B-D7C7423256D5Q36477472-A4103CDD-3DE0-4131-BF14-91BA5E9D1192Q37058565-09D25168-AB4E-4E41-BB86-F142A8B59965Q37276787-77C1A67E-C0B7-468E-B61D-562C58E46337Q38059459-1E8F2CAF-8744-4A98-948D-38ED180C32E5Q38649246-117111FC-718A-4FCA-A6B1-9006FF5F0AD1Q38793513-D3DBD84C-1958-4753-BF5B-F0C9EB40B898Q38936954-652B7F96-9B39-48D7-9367-FE95AA26B12CQ40153822-6AA664DF-1076-4E94-8B07-A50D17C9ADB9Q40289711-98E639CB-E8E2-4323-A6D7-D19FF378C022Q41009192-5892DAAF-27ED-4808-9E77-A7D3F43781C0Q41199736-ED4044FE-6070-4E7E-B973-0D5DA1856F84Q41752437-7D9F938D-783B-48F6-9054-CA083B818C67Q43160934-45609A74-C726-4CDE-BDE0-7D9F900DEB19Q47216089-5B71C9CA-B6BA-440B-A682-3728619172FEQ49166002-425766D6-91BE-406C-A820-BC478FC26850Q51545555-11D536BD-72A2-4501-9C79-31865E73BF62Q51619263-6B256C01-24AC-4997-9539-B66241663FE8Q55361229-8687D86A-58A0-4292-B2F8-4199E908AAEF
P2860
Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@ast
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@en
type
label
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@ast
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@en
prefLabel
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@ast
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@en
P2093
P2860
P356
P1476
Clinical course of lung physio ...... erma Lung Study Placebo Group.
@en
P2093
Chi-Hong Tseng
Daniel E Furst
Dinesh Khanna
Donald P Tashkin
James R Seibold
Jonathan Goldin
Michael D Roth
Niloofar Farmani
Philip J Clements
Rajeev Saggar
P2860
P304
P356
10.1002/ART.30467
P577
2011-10-01T00:00:00Z